Search Results 1761-1770 of 17826 for Substance+dependence

  1. Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

    ... drug, during the study therapy (including dose interruptions), and for 28 days after discontinuation of the study or longer as required by local guidelines.

  2. Device Evaluation for Point of Care Anticoagulation Testing - Mayo Clinic

    By condition, treatment or drug name. Search tips. Device Evaluation for Point of Care Anticoagulation Testing. Print details. Share; Facebook · Twitter.

  3. Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function - Mayo Clinic

    Received an investigational drug within 1 month prior to dosing; Patients with an allergy to iodine. Female subject who is pregnant or breastfeeding; In the ...

  4. New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System - Mayo Clinic

    Participating in another investigational drug or device study that may conflict with the objectives, follow-up or testing of this study;; Conditions likely ...

  5. Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) - Mayo Clinic

    The failed or intolerant therapy must include corticosteroids and at least one other drug. Candidates can be adults and children over the age of 6 ...

  6. General Internal Medicine - Clinical trials

    Rochester, Minn. The purpose of this study is test the effectiveness of the senolytic drug (Fisetin) in reducing senescent cell abundance in blood in elderly ...

  7. Medical Research & Education - Mayo Clinic News Network

    Cautious optimism for early results of new Alzheimer's drug featured image. Featured News. Cautious optimism for early results of new Alzheimer's drug. Ian ...

  8. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    By condition, treatment or drug name. Search tips. Erlotinib Hydrochloride and ... drug(s); Patients with known human immunodeficiency virus (HIV) disease ...

  9. Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation - Mayo Clinic

    ... drug or completely abstain from heterosexual intercourse. Kidney transplant recipients (living and deceased donors) who received a transplant in the last 3 ...

  10. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.